It is controversially discussed whether human IgM 1 IgD 1 CD27
Introduction
Traditionally, IgM + IgD + B cells were considered as naive B cells and class-switched B cells as memory B cells. However, the human peripheral blood (PB) contains a distinct population of IgM + IgD + CD27 + B cells that is characterized by somatically mutated Ig variable region (IgV) genes (1) (2) (3) . Because the process of somatic hypermutation, which generates IgV gene mutations, is linked to antigen-activated B cells proliferating in germinal centres (GC) in secondary lymphoid organs in the course of T-dependent immune responses (4, 5) , it has been proposed that IgM + IgD + CD27
+ PB B cells were generated in GC reactions and hence represent a subpopulation of human memory B cells (1) . A similar population of somatically mutated IgM + IgD + CD27 + B cells with a presumed GC origin was also identified in human spleens (6) . However, recently other scenarios for the generation of these cells have been proposed (7) . On the one hand, they may derive from a separate B-cell developmental pathway involving somatic hypermutation during antigenindependent primary V gene diversification, similar to what has been described for sheep and rabbits (8) (9) (10) . On the other hand, it was speculated that these mutated IgM + IgD + B cells might be derived from T-independent immune responses (11) . As IgM + IgD + CD27 + B cells account for ;20% of PB B cells in healthy adults (1, 3) and are also found in lymphoid tissues (6, 12) , it is important to clarify their generation.
If one assumes a GC origin of IgM + IgD + CD27 + B cells, two situations can be envisioned. First, these cells may be generated from typical GC B-cell clones when a fraction of clone members is positively selected to leave the GC and differentiate into memory B cells without undergoing class switch recombination. As IgM + IgD + CD27 + B cells usually show ;2-fold lower somatic mutation load than class-switched memory B cells, these cells may in general leave the GC earlier than class-switched B cells that undergo additional rounds of proliferation and mutation. Second, but not mutually exclusive, IgM + IgD + CD27 + B cells might be generated in distinct GC that are specialized in the generation of such memory B cells. IgD-positive GC B cells have indeed been described in numerous studies (13) (14) (15) (16) (17) (18) . One study characterized by flowcytomteric analysis IgM + IgD + CD38 + tonsillar B cells that carry unmutated or very lowly mutated V genes and are presumably GC founder cells (14) . A quite unusual population of GC B cells is characterized by the expression of IgD in the complete absence of IgM (17) . These cells have undergone an unusual class switch recombination leading to loss of the Cl gene, carry highly mutated IgV genes, show a highly biased V H gene usage, preferentially express k light chains and give rise to IgD-only memory B cells and plasma cells (1, 17, 19, 20) . It appears that these cells are generated in particular GC in which most of the B-cell clones undergo a differentiation along this pathway (17, 20) . However, a further study described a third type of IgD + GC B cells. Lens et al. (16) identified in ;10% of human tonsils GC that are characterized by IgM + IgD + B cells. The co-expression of IgM on at least a large fraction of the IgD + GC B cells distinguishes them from IgDonly B cells, and the fact that these cells dominate fully developed GC and are CD38
À argues that they are also not GC founder B cells (15, 16) . Notably, these IgM + IgD + GC B cells were also described to co-express CD70, a member of the tumour necrosis factor superfamily that is otherwise rarely expressed by B cells (15, 16) .
In the present study, we aimed to molecularly characterize human IgM + IgD + GC B cells as a potential precursor population of IgM
+

IgD
+ CD27 + PB B cells. To this end, we screened human tonsils for IgD + CD70 + GC and studied the clonal composition and V gene mutation status of microdissected IgD + GC B cells.
Methods
Tonsillar samples
Tonsils for the isolation and investigation of GC B cells were obtained from children and adolescents undergoing routine tonsillectomy. All samples were collected with permission of the donors. Approval by the Internal Review Board in Essen was obtained.
Immunohistochemistry
Immunohistochemical stainings were performed on 8-lm thick tonsillar frozen tissue sections. The sections were stained with antibodies against IgD (clone IgD26, Dako, Hamburg, Germany or Genetex, San Antonio, TX, USA), CD70 (clone HNE.51, Dako or clone BU.69, Ancell, Bayport, NY, USA), Ki67 (Dako) or CD3 (clone UCHT1, Dako). A biotinylated rabbit antimouse F(ab) fragment (Dako) was use as secondary antibody. The stainings were developed with a streptavidin-AP complex (Dako) and Fast Red as substrate (Biogenex, San Ramon, CA, USA) plus levamisol (Dako).
Microdissection of single IgD + GC B cells
Eight-micrometer thick frozen tonsillar sections were mounted on membrane-covered slides (PALM, Munich, Germany) and immunohistochemically stained for IgD as described above. Microdissection was performed using the laser microdissection and pressure catapulting technique with a UV laser beam (PALM). IgD + GC B cells were isolated form one GC (GC1) as single cells.
Single-cell PCR and sequence analysis
Single cells of GC1 were digested with 0.25 mg ml À1 proteinase K in 20 ll High Fidelity reaction buffer (Roche, Mannheim, Germany) for 4 h at 55°C followed by a 10-min enzyme inactivation at 95°C. A seminested PCR approach was used to amplify V H , V j and V k gene rearrangements. Family-specific primers for the V H leader region and primers binding to sequences within framework region (FR)1 of human V j and V k genes were combined with two sets of nested primers for the corresponding joining regions as described (21, 22) . High fidelity DNA polymerase mixture (Roche) was used in the first round of PCR, and Taq DNA polymerase (Fermentas, Ontario, Canada) in the second round. Amplificates were gel-purified with QIAEX II gel extraction kit (Qiagen, Hilden, Germany) and directly sequenced using the BigDye Deoxy sequencing kit (Applied Biosystems, Weiterstadt, Germany) and an automatic sequencer (ABI3100, Applied Biosystems). The sequences were analyzed using DNASIS software (Pharmacia, Uppsala, Sweden) and the IMGT/V-Quest database (http://imgt .cines.fr/IMGT_vquest/vquest?livret=0&Option=humanIg).
Microdissection of GC areas, RNA isolation and reverse transcription
Consecutive frozen tissue sections of tonsils harbouring IgD + GC were mounted on UV-irradiated membrane-covered slides (PALM) and stained with cresylviolet. UV irradiation of the slides and the ethanol-based cresyl violet staining were performed to avoid RNA degradation. Total IgD + GC (identified by immunohistochemical staining of adjacent sections) were isolated with the laser microdissection technique as described above. Overall, ;1500-2000 GC cells were isolated and pooled from three adjacant sections per GC. The tissue was directly catapulted in RLT buffer followed by RNA isolation with the RNeasy Micro Kit (Qiagen). cDNA synthesis was carried out with Sensiscript-RT (Qiagen), using random hexamers as primers (Operon, Ebersberg, Germany).
V H 4-34 clone-specific reverse transcription-PCR
For the GC B-cell clone detected in the single-cell analysis of IgD + B cells of GC1, we designed a V H gene segmentspecific primer (V H 4-34cl1: 5#-TGTCTATGGTGGGCCCTT-CAGTGGC-3#) that binds to part of the FR1 of the V H gene rearrangement. To preferentially amplify clone members, the primer differs in two positions near the 3# end from the V H 4-34 germline gene, where the clone members have shared point mutations. The PCR was performed in a seminested protocol. V H 4-34cl1 was combined in the first round either with a Cl primer (5#-AAAGTGATGGAGTCGGGAAGGAAGTC-3#) located in the first exon of the Cl gene or with a Cd primer (5#-GCTGCTTGTCATGTAGTAGCGTCC-3#), located in the first exon of the Cd gene. Both first rounds were performed under the same conditions using High Fidelity DNA polymerase mixture (Roche). A primary denaturation step of 95°C for 4 min was followed by 44 cycles of 50 s at 95°C, 30 s at 62°C and 1 min at 72°C. One microlitre of the first round reactions was used as template for the second rounds. The second rounds of PCR were performed with the same gene-segment-specific V H primer and either an internal Cl primer (5#-ATACGAGCAGCGTGGCCGTTGGCTG-3#) or a nested J H primer for the first round amplificate of Cd transcripts. PCR conditions of the second round were identical with first round conditions except the use of Taq DNA polymerase (Fermentas) and 50-lM betain (Sigma, St Louis, MO, USA). Amplificates were gel-purified and cloned using the pGEM-T-Easy Vector System I (Promega, Madison, WI, USA) and XL1-Blue competent cells (Stratagene, La Jolla, CA, USA). Multiple isolated plasmids from cloned PCR products were sequenced and analyzed as described above.
Isolation of tonsillar B cells and flow cytometry analysis
Tonsils were immediately placed on ice and minced in PBS/ 0.5% BSA. Tonsillar mononuclear cells were isolated by FicollPaque density centrifugation (Pancoll, Pan-Biotech, Aidenbach, Germany) and CD19
+ B cells were enriched to >96% purity by magnetic cell separation using CD19 MicroBeads and the MACS system (Miltenyi Biotech, Bergisch Gladbach, Germany). The B-cell suspension was stained with anti-CD70-PE (Ancell), anti-IgM-FITC, anti-CD38-APC and biotinylated anti-IgD coupled with streptavidin-conjugated Per-CP or PE-Cy-7 (all Becton Dickinson, Heidelberg, Germany). Stainings were evaluated on a FACSCanto flow cytometer (Becton Dickinson).
PAGE and cloning of size-selected amplified V gene rearrangements
Consecutive frozen sections of GCs containing IgD
+ GC B cells were stained with cresylviolet and GCs were microdissected. Microdissection, RNA isolation and reverse transcription (RT) were performed for three GC (GC2-4) as described above. Seminested PCRs were performed in two-rounded protocols. First rounds contained a V H 3 familyspecific primer binding to FR2 of V H 3 genes (23) (V H 3 FR2: 5#-GGTCCGCCAGGCTCCAGGGAA-3#) combined with first round Cl and Cd primers described above. Amplification was performed using Taq DNA polymerase (Fermentas). A primary denaturation step of 4 min at 95°C was followed by 35 cycles of 30 s at 95°C, 30 s at 64°C and 1 min at 72°C. One microlitre of the first round was used as template for the second rounds, using the same reaction conditions. In the second round reactions, the FR2 primer was combined in separate reactions with either an internal Cl primer (5#-ATACGAGCAGCGTGGCCGTTGGCTG-3#) or an internal Cd primer (5#-GTTATCCTTTGGGTGTCTGCACCCTG-3#) with binding sites in the Cl and Cd genes, respectively, of identical distance to the 3# end of rearranged V H genes. PCR products were separated on 6% PAGE gels. Gels were fixed, stained and developed with the Silver sequence DNA staining kit (Promega) according to the manufacturer's recommendations. IgM and IgD PCR products of equal size in both lanes were cut out of the gel and resolved in 50 ll Tris-EDTA buffer over night at room temperature. Twenty-five microlitres of the solution were precipitated, re-suspended in 5-ll water and re-amplified for 35 PCR cycles. Products were gel-purified, cloned, sequenced and analyzed as described above.
RT-PCR analysis of two GC for clonally related B cells expressing distinct isotypes
GC cells of two further GC (GC5 and 6) from different tonsils were microdissected as pools of ;1500-2000 cells per GC as described above. GC5 is derived from the same tonsil as GC1. RNA was isolated and reverse transcribed with random hexamers (see above). A two-rounded PCR was first performed with a V H 3 FR1 family-specific primer (reviewed in ref. 24 ) and two nested Cd primers for the first (5#-CATGC-CAGGACCACAGGGCTGTTATC-3#) and second round (5#-GTTATCCTTTGGGTGTCTGCACCCTG-3#) of PCR. As no amplificate was obtained for GC6, a further aliquot of the cDNA was tested with a V H 4 FRI primer (24) (V H 4 is the second most frequently used V H gene family after V H 3) and the same Cd primers, now resulting in a PCR product. PCR products were cloned into plasmids as described above and multiple plasmids were isolated and sequenced. Upon identification of dominant clones among the two amplificates, clone-specific primers were designed, binding to the 3# half of complementarity determining region (CDR)3, including part of the J H gene segments (V H 3 clone from GC5: 5#-GACGTC-CATGTACTGGGGGCCGG-3#; V H 4 clone from GC6: 5#-GCTCTTATGACTTCCCGAACCAGATGG-3#). To test the presence of clone members among Cl, Cc and Ca transcripts, separate first rounds were performed with the V H 3 or V H 4 primer and with respective C primers (Cl: 5#-AAAGTGATG-GAGTCGGGAAGGAAGTC-3#; Cc: 5#-TCCACCTTGGTGTTG-CTGGGCTTGTG-3# and Ca: 5#-GTGTAGTGCTTCACGTGG-CATGTCAC-3#), followed by a clone-specific second round PCR with the V H 3 or V H 4 primer and the two clone-specific CDR3 primers. As a positive control for successful amplification in the first round or PCR, second rounds were performed for all four isotypes with the V H 3 or V H 4 primer and either a J H primer mix (3# J H mix; reviewed in ref. 4) or internal C primers Cl: 5#-TCGTATCCGACGGGGAATTCTCACAG-3#; Cc: 5#-TAGAGTCCTGAGGACTGTAGGACA-3# and Ca: 5'-CTTTC-GCTCCAGGTCACACTGAGTG-3'). PCR products obtained with the clone-specific primers were cloned into plasmids and multiple plasmids were sequenced. All PCRs in this experiment were performed with High Fidelity DNA polymerase mixture (Roche), and before cloning of a PCR product, single A bases were added to the 3# ends of the DNA strands by Taq DNA polymerase (Fermentas) to allow cloning in the pGEM-T-Easy vector.
Results
Immunohistochemical stainings
It was previously reported that ;10% of human tonsils contain GC with B cells expressing CD70 and IgD and that these cells mainly co-express IgM on their cell surface (15, 16) . To confirm this finding and identify IgM + IgD + GC for molecular analysis, we first screened 67 tonsils by staining consecutive frozen tissue sections with antibodies against IgD and CD70, the proliferation marker Ki67 and the T cell IgD-positive human germinal centres 291 surface marker CD3 (Fig. 1) . Immunohistochemical stainings against IgM were not performed because they cannot reliably be evaluated due to the high background caused by IgM-containing complexes on follicular dendritic cell networks. GC were depicted as positive for IgD or CD70 when they contained at least 30% cells expressing IgD or CD70. Ten of 67 tonsils analyzed contained GC positive for IgD. In most instances, when IgD + GC were identified, multiple GC in these tonsils had this phenotype. Three of these tonsils additionally contained GC positive for CD70. All CD70 + GC were also IgD positive. Thus, we confirm the existence of GC dominated by IgD + GC B cells in 10-15% of human tonsils, although in our analysis only a fraction of them was also positive for CD70. The cells also carry a non-productive unmutated V j 2-30*01/ J j 1*01 joint. The heavy and one light chain genes were somatically mutated, with average mutation frequencies of 3.8 and 3.6%, respectively. The clone members exhibit shared and unique mutations. A genealogical tree for the V H gene rearrangement is shown in Fig. 2 . Thus, this large IgD + GC B-cell clone undergoes ongoing somatic hypermutation during clonal expansion like typical GC B cells. The large size of the clone, indicating multiple rounds of proliferation, and the high number of V gene mutations (5-21) excluded that these are GC founder B cells. Although only two clone members were identified for clone B, the high mutation frequencies of these cells (7.4 and 7.8%) also indicate that these are members of a mature GC B-cell clone.
As immunohistochemical stainings of GC for IgM are difficult to evaluate, we needed to clarify whether the GC we had analyzed represents an IgM + IgD + GC or an IgD-only GC. To this end, we microdissected parts of the same GC from adjacent tissue sections, isolated RNA and performed an RT-PCR with a V H primer that should preferentially amplify members of clone A as it includes two point mutations not present in the V H 4-34 germline gene and primers for Cl and Cd. PCR products were cloned and sequenced. If rearrangements belonging to clone A were amplified both in the Cl and Cd PCR, this would confirm that we were studying IgM + IgD + GC B cells. Among seven sequences obtained from the V H -Cd PCR four belonged to clone A, whereas the three others, from which one was unmutated, derived from independent rearrangements of the V H 4-34 gene. The clonal rearrangements shared some mutations with the originally identified clone members and fitted well into the genealogical tree (Fig. 2) . However, among 17 sequences obtained from the V H -Cl amplificate, none was related to clone A. Again, all these rearrangements used the V H 4-34 gene. Eleven of these V H region genes harbour somatic mutations and among these rearrangements, two clones were identified. The first clone had two members with low mutation frequencies (0.9 and 1.8%), whereas the second clone with four rearrangements showing intraclonal diversity had a mean V gene mutation frequency of 4.5% (data not shown). These l transcripts may derive from B cells of developing GC B-cell clones that have not yet undergone class switching. Taken together, the lack of l heavy chain transcripts belonging to clone A strongly indicates that the GC B-cell clone we analyzed represents an IgD-only B-cell clone with deleted Cl gene and not an IgM + IgD + GC clone. Furthermore, this analysis suggests that CD70 can also be expressed by IgD-only GC B cells.
Flow cytometric analysis of tonsillar B cells
Since the immunohistochemical stainings were not suitable to distinguish between IgM + IgD + and IgD-only GC, we performed flow cytometric studies to search for IgM
+
IgD
+ GC B cells. We included CD70 in the stainings and also CD38, as GC B cells are usually CD38 positive, although it had 
+ CD38 + population (IgD-only GC cells), and these IgD-only GC B cells also expressed CD70 at low to moderate level (Fig. 3) + GC and performed RT-PCR with a V H 3 family-specific primer combined with Cl and Cd primers with binding sites in the Cl and Cd genes, respectively, of identical distance to the 3# end of rearranged V H genes. To enhance the chance to identify clonally related Igl and Igd transcripts, PCR products were separated by PAGE and bands of identical size were isolated from the gel, reamplified, cloned and sequenced. We analyzed three GC (GC2-4) from three different tonsils. Between 8 and 21 rearrangements were sequenced per isolated PCR band ( Table 2) . Thirty-nine and 35 of the 42 Igl and 36 Igd transcripts, respectively, were somatically mutated. Notably, the average mutation frequencies of Igl transcripts (1.4-2.7%) were in each of the three GC considerably lower than the average mutation frequencies of the Igd transcripts (5.4-13.0%). From each of the excised bands, we identified clonally related sequences with intraclonal sequence diversity, demonstrating their derivation from expanding and actively mutating GC B-cell clones ( Fig. 4A and B) . Importantly, however, in no instance, clonally related Igl and Igd transcripts were observed. A further difference between the l and d rearrangements was the preferential usage of V H 3-30 among the V H 3 gene rearrangements in the Igd amplificates (51.6%) compared with Igl rearrangements (11.6%). The high mutation load of the d transcripts and their highly biased usage of the V H 3-30 gene segment are hallmarks of IgD-only B cells (17, 20) , and therefore, these features together with the fact that we never amplified l transcripts clonally related to any of the unique or clonally expanded d transcripts strongly indicate that these three IgD + GC were composed of IgD-only GC B-cell clones, but not of IgM + IgD + GC B cells.
Having seen that large B-cell clones could be repeatedly identified from IgD + GC, we decided to analyse two further IgD + GC (GC5 and 6) avoiding the polyacrylamide gel extraction procedure by direct cloning and sequencing of V H gene rearrangements from microdissected GC. In this experiment, we also wanted to address the question whether IgD + GC B-cell clones also give rise to class-switched clone members. Initially, a seminested RT-PCR was performed with a V H 3 (and for GC6 also a V H 4) FR1 family-specific primer and nested Cd primers. From GC5, a dominant V H 3-30*03-using clone was amplified, and from GC6, a dominant clone with a V H 4-34*01 rearrangement was amplified (Table 3) . The clonal V H 3 and V H 4 sequences showed 8.1-10.7% and 4.0-5.5% mutation, respectively, and pronounced intraclonal diversification (Fig. 4C and D) . From these two clones, clone-specific CDR3 primers were designed. In seminested PCRs, the V H FR1 primers were combined with All V j rearrangements were unmutated, likely due to inactivation by rearrangement of the j deleting element (25, 26) and are therefore not informative regarding somatic hypermutation in the clone. Cl, Cd, Ca and Cc primers in the first round and in the second rounds, the V H FR1 primers were combined with the internal clone-specific primers. For the V H 3 clone from GC5, a product was obtained for Cl and Cd transcripts, but not for Ca or Cc transcripts (data not shown). The amplificates from the l and d transcripts were cloned and several plasmids were sequenced. This confirmed that sequences belonging to the V H 3-30 clone were obtained. The l and d transcripts were similarly mutated and found intermingled in the genealogical tree, suggesting that this is a mutating IgM + IgD + GC B-cell clone (Fig. 4C) . For the V H 4-34 clone from GC6, the clone-specific PCR revealed a product only for the Cd trancripts, but not for the Cl, Ca or Cc transcripts (Fig. 5A) . The V H 4-34 amplificate from the Cd transcripts Although IgM and IgD bands of the same size were isolated from the gels, not all sequences had the same size, some were slightly longer or shorter than the bulk of the sequences, presumably because of incomplete separation of DNA molecules differing by a few base pairs in length during gel electrophoresis. Importantly, however, for all pairs of bands also sequences of the same size were obtained, so that the identification of clonally related l and d transcripts should have been possible, in particular when looking for expanding GC B-cell clones. In GC4 several sequences were derived from rearrangements of V H 4 genes. This was due to cross-reaction of the V H 3 family FR2 primer with selected V H 4 gene segments.
was directly sequenced, confirming that it belonged to the V H 4-34 GC B-cell clone (data not shown). Thus, this is a further IgD-only GC B-cell clone. To rule out that the absence of amplification products for Ca and Cc (and Cl in case of GC6) transcripts was due to a failure in the first round of PCR, seminested PCRs were performed with a J H primer mix or nested C primers, which gave rise to PCR products of the expected length, presumably derived from other B cells present in the GC, but not belonging to the IgD + B-cell clones ( Fig. 5B and C, and data not shown) . Thus, in neither of the two GC could clone members class switched to IgG or IgA be detected.
Discussion
As the origin of human IgM
+
IgD
+ CD27 + B cells with somatically mutated IgV genes is debated, we aimed to clarify whether at least a fraction of these cells might derive from specific GC with dominant populations of IgM + IgD + B cells. Such GC have indeed been described to occur in human IgD-positive human germinal centres 295 tonsils and to be further characterized by expression of CD70 (15, 16) . We could confirm by immunohistochemistry that ;10% of human tonsils harbour GC with at least 30% IgD + B cells, although in our analysis only a fraction of these also co-express CD70. Due to the high background staining for IgM in GC, reliable evaluation of IgM expression was not possible by immunohistochemistry. Notably, when we observed IgD + GC, usually multiple GC in the respective tonsils had the IgD + phenotype, in support of the idea that they develop in particular immune responses which promote retention of IgD expression during the GC passage of the antigen-activated B cells.
The detailed single-cell analysis of one IgD + CD70 + GC revealed that this was a mature GC with a very large GC B-cell clone characterized by a high load of somatic mutations and extensive intraclonal diversity, as is typical for GC B-cell clones (4). Thus, we could exclude that this is an early GC composed of GC founder cells. The further analysis of the large GC B-cell clone for IgM expression by RT-PCR, however, revealed that we had analyzed an IgD-only GC B-cell clone. Such B cells have deleted the Cl gene, so that they express IgD in the complete absence of IgM (17, 19) . These cells give rise to IgD-producing plasma cells and IgD-only memory B cells, but cannot be the precursors of IgM + IgD + CD27 + PB B cells (1, 19, 20) . As the GC was initially selected because of CD70 expression, we can conclude that CD70 positivity is not a specific feature of IgM + IgD + GC B cells but can also be found on IgD-only GC B cells. This was further supported by the flow cytometric analysis, which revealed IgD-only GC B cells co-expressing CD70 in 3 of 30 tonsils analyzed. The previous analyses of CD70 expression on tonsillar B cells indeed reported that IgM expression was heterogeneous on the CD70 + B cells (15, 16) , so that the IgD + CD70 + GC B cells characterized in these studies may well have included IgD-only GC B cells, which was not directly tested in those studies by multi-colour stainings.
To analyse additional IgD + GC at the molecular level, we developed an RT-PCR-based approach combined with a gelbased analysis to search for IgM and IgD co-expressing GC B-cell clones. Three GC we analyzed in this way. Although expanded clones of IgD + GC B cells were identified in each of these GC, in no instance did we amplify Igl transcripts from the same B-cell clones. This strongly indicated that also these were IgD-only GC B-cell clones, and not IgM + IgD + GC cells. This is indeed supported by the preferential usage of the V H 3-30 gene segment by the IgD + GC B cells we analyzed, which is a hallmark of IgD-only B cells, and the high somatic mutation load of these cells, another key feature of IgD-only B cells (1, 17, 19, 20) . Notably, also the V H 4-34 gene, which was used by the first GC, we analyzed is preferentially used by IgD-only GC B cells (27) .
In a third molecular approach, we studied two further IgD + GC by sequencing amplified and cloned V H 3-or V H 4-Cd transcripts. In each GC, a dominant clone was identified and this was used to design clone-specific primers. With these primers, no clonally related Cl transcripts were detected for the V H 4-34 clone from GC6, showing that this represents a further GC with an IgD-only B-cell clone. Interestingly, however, for the V H 3-30 clone from GC5, clone members were found among l transcripts, and these showed a similar mutation pattern as the d transcripts and were found intermingled with the d transcripts in the genealogical tree (Fig. 4C ). This strongly argues that here we have identified a mature IgM + IgD + GC B-cell clone undergoing multiple rounds of proliferation and mutation and keeping IgM and IgD expression. It is therefore likely that members of this clone will also leave the GC as IgM + IgD + B cells and A somewhat surprising finding was that for the two IgD + B-cell clones (one IgD-only and the one IgM + IgD + ) that were analyzed for the existence of clone members switched to IgG or IgA, no such members were found, although a highly sensitive two-rounded PCR was performed. Although we formally cannot exclude that lack of a PCR product was due to mutations in the binding sites for the V H or CDR3 clonespecific primers in (nearly) all Cc or Ca transcripts of these clones, this appears highly unlikely. Therefore, this analysis indicates that class switching is tightly regulated in these particular IgD + GC B-cell clones and either does not take place at all (the IgM + IgD + clone) or only involved the unusual class switching resulting in Cl deletion (IgD-only clone). In the latter case, this is well compatible with a scenario in which IgD-only B cells are generated in specific immune responses in which they need to retain IgD expression as the activating and selecting antigen may not only bind to the V domains but also to motifs of the IgD constant region (20) .
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